Creative Biolabs

Nanoemulsion-Based Delivery Strategies: Mechanisms, Benefits, and Real-World Uses

Nanoemulsion-based delivery strategies are transforming how modern formulations handle ingredients that are difficult to dissolve or absorb. By breaking oil droplets into nanoscale sizes, these systems improve stability, boost absorption, and allow active compounds to perform more effectively across oral, topical, and transdermal formats. As R&D teams search for reliable ways to enhance product performance, nanoemulsions continue to stand out for their versatility and efficiency. At Creative Biolabs, these delivery approaches are integrated into advanced platforms designed to support innovative research and next-generation formulation development.

Introduction: Nanoemulsions in Modern Delivery Strategies

Nanoemulsions (NEs), colloidal dispersions with droplet sizes ranging from 20 to 500 nm, have emerged as transformative tools in modern delivery strategies across pharmaceuticals, agriculture, and food industries. By leveraging their high surface area, tunable structure, and enhanced dispersion capabilities, these systems overcome key limitations of conventional formulations, such as poor solubility, low bioavailability, and inadequate stability. In pharmaceuticals, they boost the efficacy of water-insoluble drugs and sensitive compounds; in agriculture, they enable targeted, eco-friendly pesticide delivery; in food, they improve nutrient encapsulation and shelf life. Their versatility, from oil-in-water to water-in-oil configurations, which combined with advancements, such as solidification into S-SNEDDS or integration with oleogels, further expands their applicability. As demand for efficient, safe delivery systems grows, nanoemulsions stand at the forefront, driving innovations that balance performance, sustainability, and user compliance.

What Are Nanoemulsions?

A nanoemulsion is a mixture of two liquids that do not normally mix, such as oil and water. One liquid is broken down into tiny droplets and spread throughout the other.

Key features:

Illustration comparing two types of nanoemulsions: Water-in-Oil (W/O) nanoemulsion with water droplets containing active drugs dispersed in oil, and Oil-in-Water (O/W) nanoemulsion with oil droplets containing active drugs dispersed in water, highlighting their structural differences for targeted delivery strategies. (OA Literature)Fig.1 Types of nanoemulsions.3

Because the droplets are so small, nanoemulsions often look clear or slightly cloudy instead of milky. This small size is what makes nanoemulsion-based delivery strategies powerful for modern formulations.

How Nanoemulsions Work in Delivery

Nanoemulsion-based delivery strategies mainly rely on three simple physical principles.

More surface area for absorption

When oil droplets are very small, their total surface area becomes huge. This large surface area allows more contact with biological membranes, which can support better absorption of active ingredients.

Improved solubility of oily molecules

Many drugs, vitamins, flavors, and cosmetic actives are oil-soluble. In a nanoemulsion, these molecules are held in tiny oil droplets, which can be dispersed in water-based systems such as beverages, lotions, or injectable solutions.

Possible control over release

By changing the oil phase, surfactants, and droplet size, scientists can design nanoemulsions that release their payload faster or more slowly. This helps tune how long the active ingredient stays available in the body or on the skin.

Because of these features, nanoemulsion-based delivery strategies are used across many routes, including oral, topical, transdermal, and sometimes parenteral administration under research settings.

Core Advantages of Nanoemulsion-Based Delivery Strategies

Main benefits of nanoemulsion delivery systems include:

Because of these advantages, nanoemulsion-based delivery strategies are often chosen when traditional emulsions or simple solutions are not enough.

Nanoemulsion vs. Microemulsion: Key Differences

People often confuse nanoemulsions with microemulsions, but these colloidal dispersions have distinct properties that directly impact their performance in delivery strategies. Table 1 compares nanoemulsions and microemulsions on four key delivery-relevant traits. Because nanoemulsions can be designed with moderate surfactant amounts and tailored droplet size, they are often preferred for scalable delivery strategies — whether for pharmaceuticals, food, or agriculture. Unlike microemulsions, their requirements for lower surfactant levels reduce regulatory hurdles and improve biocompatibility while their tailored droplet sizes enable enhanced target specificity (e.g., penetrating cell membranes or tissue barriers), a key advantage for modern delivery applications.

Table 1 Comparison between nanoemulsions and microemulsions.

Characteristic Nanoemulsions Microemulsions
Droplet Size 20–200 nm (consistent, narrow range) 100–500 nm (broader, system-dependent)
Stability Profile Kinetically stable (metastable; resists coalescence temporarily but may separate over time without stabilizers) Thermodynamically stable (forms spontaneously, remains uniform indefinitely under set conditions like temperature/pH)
Surfactant Requirement Lower (reduces toxicity risks and production costs, ideal for biocompatible formulations) High (often needs co-surfactants to stabilize, increasing formulation complexity and potential side effects)
Appearance Clear to slightly cloudy (depends on droplet concentration; minimal light scattering) Typically opaque or more cloudy (larger droplets cause greater light scattering)

How Nanoemulsions Are Made: Formulation Methods and Equipment

The method used to create a nanoemulsion has a strong impact on droplet size, stability, and scalability—key factors for translating lab-scale innovations into clinical or industrial applications. At Creative Biolabs, we integrate these formulation techniques with our expertise in targeted delivery systems, ensuring nanoemulsions not only meet structural requirements but also align with precision therapy goals.

Common High-Energy Methods

High-pressure homogenization

A coarse emulsion is forced through a narrow gap at very high pressure (10-100 atm), generating strong shear and turbulence that break down droplets into the nano range (20-500 nm). This method is ideal for large-scale production, offering a consistent droplet size distribution critical for therapeutic consistency.

Ultrasonic (sonication) processing

High-frequency sound waves create intense local cavitation and shear forces that split larger droplets into uniform nanosized particles. We use bench-top sonicators for early formulation screening and scalable ultrasonic equipment for pilot-scale production, ensuring compatibility with sensitive payloads such as peptides or antibodies.

Microfluidization

Fluids are pushed through microchannels at high velocities, where they collide with each other or channel walls, producing ultra-fine droplets with a narrow size distribution. This technique is favored for precision formulations, such as nanoemulsions paired with our targeting modules (e.g., functionalized lipids or aptamers) to enhance site-specific accumulation.

Low-Energy Methods

Phase Inversion Temperature (PIT)

The formulation is heated or cooled beyond a critical temperature, causing a structural shift in the emulsion. By using a specially designed surfactant system (for example, nonionic surfactants with optimal HLB values), stable nanosized droplets could be produced. It is ideal for heat-sensitive payloads such as bioactive peptides, enzymes, or nucleic acids.

Spontaneous emulsification

The system is designed so that when oil and aqueous phases meet under certain conditions (e.g., controlled pH or solvent diffusion), small droplets form on their own. This low-cost, scalable method is integrated into our workflow for early-stage product development, supporting rapid iteration of nanoemulsion-based carriers.

Creative Biolabs' workflow begins with early screening. It uses simple lab tools (stirrers, bench-top sonicators) to optimize surfactant-oil-water ratios. Then the promising formulations transition to industrial-grade equipment (high-pressure homogenizers, scalable microfluidizers) that ensure high throughput, process control, and compliance with biopharmaceutical standards. Our end-to-end approach—from formulation to in vitro/in vivo validation—aligns nanoemulsion production with targeted delivery objectives, empowering the development of next-generation therapies with enhanced efficacy and minimized off-target effects.

Safety, Stability, and Regulatory Considerations

For nanoemulsion-based delivery strategies to succeed across foods, cosmetics, or research, three non-negotiable pillars must guide development: safety (rooted in trusted ingredients), stability (to avoid performance failure), and alignment with regulatory standards—all of which shape whether these systems move from lab to practical use.

Safety

Nanoemulsions used in foods, cosmetics, or research formulations are usually built from:

As Safety depends on the specific ingredients and the final application, each system requires careful evaluation and consideration.

Stability

Key stability concerns include:

To regulate these risks, researchers adjust the oil phase, surfactant type and level, and processing conditions.

Regulatory View

Regulators focus on:

For research applications, platforms like those at Creative Biolabs can support nanoemulsion-based delivery strategies within clearly defined quality frameworks and documentation standards.

Where Nanoemulsions Are Used: Key Industry Applications

Pharmaceuticals and Biologics

In pharmaceutical research, nanoemulsions are used to:

For research and preclinical projects, Creative Biolabs can help researchers to integrate nanoemulsions into broader targeted delivery workflows, such as ligand-directed systems or depot-style formulations.

Cosmetics and Personal Care

In cosmetics and personal care, nanoemulsions are used to:

Consumers are often looking for products that feel elegant but still deliver visible performance, and nanoemulsions help balance both.

Food and Beverages

Food and beverage companies use nanoemulsion-based delivery strategies to:

Because nanoemulsions can be designed using food-grade oils and surfactants, they are attractive for functional foods and beverages.

Vaccine and Adjuvant Research

In vaccine and immunology research, oil-in-water nanoemulsions can serve as:

This area continues to grow as researchers explore new nanoemulsion-based delivery strategies for complex biological molecules.

Real-World Nanoemulsion-Based Innovations

Nanoemulsions already appear in many types of commercial and research products, for example:

These examples show how flexible nanoemulsion-based delivery strategies are across product types and dosing routes.

Looking for a delivery system for your product?

Share your payload and route goals with our Targeted Delivery team. We will propose a feasibility plan, a DoE grid, and QC endpoints tailored to your needs.

Challenges and Limitations of Nanoemulsion Delivery

Although nanoemulsions are powerful tools, challenges exist in their applications.

Formulation complexity

Choosing the correct oil, surfactant, co-surfactant, and processing method can be time-consuming.

Stability over time

Long-term storage could still lead to droplet growth or phase separation.

Ingredient compatibility

Some active molecules may degrade in certain oils or surfactants or may not tolerate specific processing conditions.

Scale-up issues

Conditions that work in a small lab beaker do not always translate smoothly to production-scale equipment.

Because of these factors, many teams turn to experienced partners to design, optimize, and scale nanoemulsion-based delivery strategies.

Related Services You May Be Interested in

FAQs

What is a nanoemulsion in simple words?

A nanoemulsion is a very fine mix of oil and water where one is broken into extremely small droplets so the mixture looks uniform and stable.

Why are nanoemulsions used for delivery?

They help dissolve oily or poorly soluble ingredients and improve how those ingredients are absorbed in the body or through the skin.

What is the typical size of nanoemulsion droplets?

Most nanoemulsions have droplet sizes between about 20 and 200 nanometers.

Are nanoemulsions safe?

When nanoemulsions are made with approved or GRAS ingredients and controlled processes, they can be designed to meet safety expectations for their intended research use.

How are nanoemulsions different from normal emulsions?

Normal emulsions, like milk or salad dressing, have much larger droplets and often separate over time, while nanoemulsions have tiny droplets that stay more stable and can be clear or slightly cloudy.

How long do nanoemulsions stay stable?

Stability depends on the formula and storage conditions. Well-designed nanoemulsions can remain stable for months or longer, but each system must be tested.

Can nanoemulsions be used with multiple administration routes?

Yes, nanoemulsion-based delivery strategies can be tailored for oral, topical, transdermal, and other research-focused routes, depending on the active and excipients.

Do nanoemulsions always need high-tech equipment?

Early screening can use simple tools like magnetic stirrers and bench-top sonicators, but scale-up often relies on high-pressure homogenizers or microfluidizers.

Are nanoemulsions only for drugs?

No. They are also used for cosmetics, nutraceuticals, functional foods, and other advanced formulations.

Why work with a specialist partner?

Because formulation, scalability, and regulatory expectations can be complex, partnering with experienced teams such as Creative Biolabs can help reduce risk and speed up development.

Conclusion

Nanoemulsion-based delivery strategies give scientists and product developers a powerful way to handle challenging active ingredients. By reducing droplet size into the nanometer range, these systems improve solubility, support higher apparent bioavailability, and unlock flexible dosing routes. At the same time, they fit into real-world workflows in pharmaceuticals, cosmetics, food, and biologics research.

For teams designing next-generation formulations, working with a partner that understands nanoemulsions, targeted delivery, and scalable process design is essential. Creative Biolabs provides integrated platforms that can bring nanoemulsion-based delivery strategies from concept to validated research solutions, supported by robust scientific and technical expertise.

For Research Use Only. Not for Clinical Use.

References

  1. Jacob, S., Kather, F. S., Boddu, S. H. S., Shah, J. & Nair, A. B. "Innovations in Nanoemulsion Technology: Enhancing Drug Delivery for Oral, Parenteral, and Ophthalmic Applications." Pharmaceutics 16, 1333 (2024). https://www.mdpi.com/1999-4923/16/10/1333 .
  2. Shaker, D. S., Ishak, R. A. H., Ghoneim, A. & Elhuoni, M. A. "Nanoemulsion: A Review on Mechanisms for the Transdermal Delivery of Hydrophobic and Hydrophilic Drugs." Sci. Pharm. 87, 17 (2019). https://www.mdpi.com/2218-0532/87/3/17.
  3. Yandi Syukri, Syafira Tri Nurmala Sari, & Arba Pramundita Ramadani. "A Comprehensive Review of Solid Self Nano Emulsifying Drug Delivery System (S-SNEDDS) Technology to Enhance Nanoemulsion Stability." J Sains Farm Klin 12, 15–28 (2025). https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/1653. Distributed under Open Access license CC BY 4.0, without modification.
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry

Customer Review

Creatibe Biolabs' custom LNP was the only solution that successfully delivered our CRISPR-Cas9 payload across the blood-brain barrier with high efficiency and low toxicity.”

Dr. Evelyn Reed

Postdoctoral Researcher, Leading University

Our siRNA candidate was failing due to off-target toxicity, but Creatibe Biolabs' team rapidly redesigned our LNP using their modular platform, rescuing our preclinical program.”

Ben Carter

Project Manager

Achieving cytosolic delivery of our protein degrader with Creatibe Biolabs' exosome platform was the key to unlocking our candidate's full therapeutic potential.”

Dr. Kenji Tanaka

Principal Scientist, Large Pharma Corp

Our oncology drug's efficacy was limited by poor tumor accumulation. Creatibe Biolabs' peptide-conjugated liposomes provided the precise targeting we needed, dramatically increasing the drug's therapeutic index.”

Dr. Clara Schmidt

Senior Scientist, Oncology Innovations Inc.

We required a delivery system that would only release its payload in the tumor's acidic microenvironment. Creatibe Biolabs' pH-responsive liposomes performed flawlessly, minimizing systemic exposure.”

David Chen

Formulation Scientist

Outstanding expertise in antibody engineering.The team's attention to detail and innovative approaches have sianificantly accelerated our development timeline.

Sarah L.

Senior Research Scientist

Contact us for more information Get free consultations